Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$63.83 - $80.0 $175,723 - $220,240
-2,753 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$76.85 - $89.45 $3,842 - $4,472
-50 Reduced 1.78%
2,753 $213,000
Q4 2021

Feb 11, 2022

SELL
$74.57 - $87.19 $74 - $87
-1 Reduced 0.04%
2,803 $241,000
Q3 2021

Nov 15, 2021

BUY
$73.77 - $83.61 $442 - $501
6 Added 0.21%
2,804 $226,000
Q2 2021

Aug 12, 2021

SELL
$80.5 - $88.01 $12,880 - $14,081
-160 Reduced 5.41%
2,798 $225,000
Q1 2021

May 07, 2021

SELL
$76.38 - $86.03 $15,276 - $17,206
-200 Reduced 6.33%
2,958 $249,000
Q4 2020

Feb 10, 2021

BUY
$75.39 - $82.36 $75 - $82
1 Added 0.03%
3,158 $253,000
Q2 2020

Aug 14, 2020

BUY
$78.66 - $94.14 $7,236 - $8,660
92 Added 3.0%
3,157 $272,000
Q1 2020

May 13, 2020

SELL
$71.57 - $93.3 $4,079 - $5,318
-57 Reduced 1.83%
3,065 $249,000
Q3 2019

Nov 08, 2019

BUY
$81.4 - $89.78 $4,884 - $5,386
60 Added 1.96%
3,122 $273,000
Q2 2019

Aug 06, 2019

SELL
$73.44 - $82.41 $4,406 - $4,944
-60 Reduced 1.92%
3,062 $251,000
Q1 2019

May 10, 2019

SELL
$64.48 - $81.31 $109,616 - $138,227
-1,700 Reduced 35.26%
3,122 $254,000
Q2 2018

Aug 09, 2018

BUY
$63.43 - $75.41 $634 - $754
10 Added 0.21%
4,822 $356,000
Q1 2018

Jul 26, 2018

BUY
$62.56 - $72.26 $281,457 - $325,097
4,499 Added 1437.38%
4,812 $313,000
Q1 2018

May 03, 2018

SELL
$62.56 - $72.26 $284,585 - $328,710
-4,549 Reduced 93.56%
313 $4.81 Million
Q4 2017

Feb 06, 2018

SELL
$61.45 - $66.05 $113,682 - $122,192
-1,850 Reduced 27.56%
4,862 $0
Q3 2017

Nov 09, 2017

SELL
$59.5 - $64.61 $23,800 - $25,844
-400 Reduced 5.62%
6,712 $421,000
Q2 2017

Aug 14, 2017

BUY
N/A
7,112
7,112 $431,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.5B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Reynders Mc Veigh Capital Management, LLC Portfolio

Follow Reynders Mc Veigh Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.